The redistribution of CCR2+ and CD163+ monocytes between non-classical subpopulations was found in patients after treatment onset: NAC (for rectal cancer patients) and surgical resection (for rectal and colon cancer patients). This evidence concerns the gene CCR2 and colonic neoplasm.